The ISSCR 2019 Annual Meeting will be held June 26-29 in Los Angeles, CA.
SCB will attend the NIIMBL National Meeting in Washington, DC. with the theme of this year’s event being “Catalyzing Innovation to Improve Human Health.”
SCB will attend and exhibit at ARMI | BioFabUSA’s Spring 2019 Summit.
SCB will attend CASSS’s 2nd annual meeting of Cell & Gene Therapy Products (CGTP) focusing on manufacturing, quality and regulatory considerations that will be held June 10-12 in Bethesda, MD.
ISCT 2019 in Melbourne, Australia will focus on the latest immunotherapy innovations including immune monitoring and tumor escape.
ARM’s Cell & Gene Washington Forum & Fly-In will be held May 21-22 in Washington, D.C.
SCB will host a workshop to advance process, measurement, and analytical techniques of regenerative medicine products and services on May 15th and attend the World Advanced Therapies & Regenerative Medicine Congress.
SCB will participate in the ASTM F04 Committee Meeting May 14-17 in Denver, Colorado.
SCB’s Senior Technical Program Manager, Dawn Henke, will participate in a panel in this webinar through Cell & Gene Therapy Insights and sponsored by Be The Match BioTherapeutics. The webinar will focus on highlighting the impact outcomes data tracking has on ensuring innovative therapies are safe and effective, while also proving the retrospective data to expedite approvals and delivery.
On Friday, May 3, 2019, NIST will host and convene a one-day public workshop with stakeholders across industry, academia, non-profit, and government to discuss industry-wide measurement challenges and potential standards solutions for genome editing technologies, particularly for the development of human therapeutic products.
ASGCT’s 22nd Annual Meeting will take place April 29-May 2, 2019, in Washington, D.C.
The theme of this year’s conference will be applications and new advances in regenerative biology and biomedical engineering.
The Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mediterranean will be April 23-25 in Barcelona, Spain.
Breakthroughs in cell technologies, materials science, and biofabrication methods, particularly 3D bioprinting, have laid a foundation for large-scale manufacturing of tissues and tissue-related products. Attendees of this conference will learn from industry and academic experts on what will be needed to bring biofabrication from its current prototype stage to reproducible, manufactured tissue products in the future.
The ASTM E55 April Committee Meeting will be April 10-11 in Germany.
The 9th International Conference and Exhibition on Advanced Cell and Gene Therapy (CELL THERAPY 2019) follows the theme “Novel innovations and breakthroughs in cell and gene therapy” and will be held on March 21-22, 2019 in Rome, Italy.
This webinar, sponsored by Brooks Life Sciences, brings together speakers who will discuss the governance of biosample collections, standardization efforts and quality control harmonization for biosamples as well as global best practices for the regulatory oversight of national and commercial biobank resources.
Join ARMI | BioFabUSA, AABME and ASME at the Tissue Engineering Lexicon Working Session on Thursday, February 7th.
Join ACF Bioservices on February 6th for a webinar discussing in vitro relative potency assays for commercialization of gene therapy products.
Join FACT on January 30th for a webinar where presenters will discuss FACT requirements for exceptional release of commercial cellular therapy products and then share their centers’ processes for release of nonconforming cellular therapy products in the U.S.
The world’s largest advanced therapies partnering event will be held Tuesday, January 22nd to Friday, January 25, 2019 in Miami, FL.
By signing up, you’re agreeing to receive email from SCB. But rest assured: we respect your privacy.
